Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance
| dc.contributor.author | Demarest, James | |
| dc.contributor.author | Underwood, Mark | |
| dc.contributor.author | St. Clair, Marty | |
| dc.contributor.author | Dorey, David | |
| dc.contributor.author | Brown, Dannae | |
| dc.contributor.author | Zolopa, Andrew | |
| dc.date.accessioned | 2022-03-09T17:59:59Z | |
| dc.date.available | 2022-03-09T17:59:59Z | |
| dc.date.issued | 2018-04 | |
| dc.date.updated | 2022-03-09T17:59:58Z | |
| dc.identifier.issn | 0889-2229 | |
| dc.identifier.issn | 1931-8405 | |
| dc.identifier.uri | ||
| dc.language | en | |
| dc.publisher | Mary Ann Liebert Inc | |
| dc.relation.ispartof | AIDS Research and Human Retroviruses | |
| dc.relation.isversionof | 10.1089/aid.2017.0184 | |
| dc.title | Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance | |
| dc.type | Journal article | |
| pubs.begin-page | 343 | |
| pubs.end-page | 346 | |
| pubs.issue | 4 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Immunology | |
| pubs.publication-status | Published | |
| pubs.volume | 34 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Boffito et al_Perspectives on the Barrier to Resistance for Dolutegravir+Lamivudine a Two-Drug Antiretroviral Therapy for HIV-1 Infection_AIDS Res Hum Retro 2020.pdf
- Size:
- 108.55 KB
- Format:
- Adobe Portable Document Format